[1]TAKAHASHI K, YAMANAKA S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J]. Cell, 2006, 126(4):663-676.[2]YU J, VODYANIK M, SMUGA-OTTO K, et al. Induced pluripotent stem cell lines derived from human somatic cells[J]. Science, 2007, 318(5858):1917-1920.[3]CHAMBERLAIN S, LI X, LALANDE M. Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders[J]. Neurogenetics, 2008, 9(4):227-235.[4]DIMOS J, RODALFA K, NIAKAN K, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons[J]. Science, 2008, 321(5893):1218-1221.[5]PARK I, ZHAO R, WEST J, et al. Reprogramming of human somatic cells to pluripotency with defined factors[J]. Nature, 2008, 451(7175):141-146.[6]OKITA K, NAKAGAWA M, HYENJONG H, et al. Generation of mouse induced pluripotent stem cells without viral vectors[J]. Science, 2008, 322(5903):949-953.[7]STADTFELD M, NAGAYA M, UTIKAL J, et al. Induced pluripotent stem cells generated without viral integration[J]. Science, 2008, 322(5903):945-949.[8]KAJI K, NORRBY K, PACA A, et al. Virusfree induction of pluripotency and subsequent excision of reprogramming factors[J]. Nature, 2009, 458(7239): 771-775.[9]WOLTJEN K, MICHAEL I P, MOHSENI P, et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells [J]. Nature, 2009, 458(7239): 766-770.[10]SOLDNER F, HOCKEMEYER D, BEARD C, et al. Parkinson’s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors [J]. Cell, 2009, 136(5): 964-977.[11]ZHOU H, WU S, JOO J, et al. Generation of induced pluripotent stem cells using recombinant proteins [J]. Cell Stem Cell, 2009, 4(5):381-384.[12]KIM D, KIM C H, MOON J I, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins [J]. Cell Stem Cell, 2009, 4(6):472-476.[13]PAN C, HICKS A, CHEN H, et al. SNL fibroblast feeder layers support derivation and mainteence of human induced pluripotent stem cells [J]. J Genet Genomics, 2010, 37:241-248.[14]PAN C, LU B, CHEN H, et al. Reprogramming human fibroblasts using HIV-1 TAT recombinant proteins Oct4, Sox2, Klf4 and c-MYC [J]. Mol Biol Reports, 2010, 37:2117-2124.[15]PAN C, LAN X, CHEN H, et al. An economical single-sided antibody incubation method for western blotting [J]. J Virol Methods, 2010, 169:409-411. [16]RUSSELL J E, LIEBHABER S A. The stability of human beta-globin mRNA is dependent on structural determinants positioned within its 3′untranslated region [J]. Blood, 1996, 87: 5314-5323.[17]YU J, RUSSELL J E. Structural and functional analysis of an mRNP complex that mediates the high stability of human beta-globin mRNA [J]. Mol Cell Biol, 2001, 21:5879-5888.[18]BOYER L A, LEE T I, COLE M F, et al. Core transcriptional regulatory circuitry in human embryonic stem cells [J]. Cell, 2005, 122(6):947-956.[19]TORRES J, WATT F M. Nanog maintains pluripotency of mouse embryonic stem cells by inhibiting NFkappaB and cooperating with Stat3 [J]. Nat Cell Biol, 2008, 10(2):194-201.[20]MATTHEW A, MEHMET F Y. Innate immune suppression enables frequent transfection with RNA encoding reprogramming proteins [J].PLoS One, 2010, 5(7):e11756.[21]WARREN L, MANOS P D, AHFELDT T, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA [J]. Cell Stem Cell, 2010, 7(5):618-630. |